Stocks & Financial News
Breaking financial news 24/7 courtesy of TradingCharts.com Inc. / TFC Commodity Charts
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
To participate, dial 800-274-8461 within the U.S. or (+1) 203-518-9814 outside the U.S., access code: BIORAD. A live webcast of the conference call will also be available in the "Investor Relations" section of the company's website under "Events & Presentations" at investors.bio-rad.com. A replay of the webcast will be available for up to a year.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B) is a leader in developing, manufacturing, and marketing a broad range of products for the life science research and clinical diagnostics markets. Based in Hercules, California, Bio-Rad operates a global network of research, development, manufacturing, and sales operations with approximately 8,000 employees and $2.7 billion in revenues in 2023. Our customers include universities, research institutions, hospitals, food safety and environmental quality laboratories, and biopharmaceutical companies. Together, we develop innovative, high-quality products that advance science and save lives. To learn more, visit bio-rad.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240418334721/en/
SOURCE: Bio-Rad Laboratories, Inc.
<img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&sty=20240418334721r1&sid=cmtx6&distro=nx&lang=en" style="width:0;height:0" />
Investor Contact: Edward Chung, Investor Relations 510-741-6104 ir@bio-rad.com Media Contact: Anna Gralinska, Corporate Communications 510-741-6643 cc@bio-rad.com
COMTEX_451029784/1006/2024-04-18T09:00:05